Activation of Ras and formation of GAP complex during TPA-induced monocytic differentiation of HL-60 cells. 1994

K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
Tokyo Institute for Immunopharmacology, Inc., Toshima-kur, Japan.

In this study, it was shown that the proportion of guanosine triphosphate (GTP)-bound active Ras increased in TPA (12-o-tetradecanoyl phorbol-13-acetate)-induced monocytic differentiation of HL-60 cells. The increase of active Ras was observed at 24 hours after TPA stimulation and attained to threefold (15%) over the proportion in nontreated HL-60 cells. Herbimycin A, an inhibitor of tyrosine kinase, prevented the activation of Ras, as well as the induction of monocytic differentiation. In parallel with the activation of Ras, the proteins with molecular weights of 52, 56, 62, and 190 kD were tyrosine-phosphorylated and formed a complex with GTPase-activating protein (GAP) for Ras. In addition to the 116-kD GAP (type I GAP), the 100-kD GAP (type II GAP) molecule was markedly induced at 24 hours after TPA stimulation of HL-60 cells. These phenomena sustained for a further 24 hours during monocytic differentiation. However, they were not observed during retinoic acid-induced granulocytic differentiation of the cells. The HL-60 transfectants, which expressed a dominant inhibitory Ha-ras Asn17, showed a low level of tyrosine-phosphorylated GAP-associated proteins and did not undergo full differentiation in response to TPA. Taken together, these data indicate that the activation of Ras and GAP complex formation mutually correlate and function downstream of protein-tyrosine kinases in the signaling pathway for monocytic differentiation of HL-60 cells.

UI MeSH Term Description Entries
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011809 Quinones Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte

Related Publications

K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
September 2004, Biochemical and biophysical research communications,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
January 2018, PloS one,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
January 2012, Asian Pacific journal of cancer prevention : APJCP,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
January 1993, Journal of immunology (Baltimore, Md. : 1950),
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
March 2009, Free radical biology & medicine,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
April 1993, Biochemical and biophysical research communications,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
August 2007, Toxicology in vitro : an international journal published in association with BIBRA,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
January 1991, Journal of immunology (Baltimore, Md. : 1950),
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
April 1995, Leukemia research,
K Katagiri, and S Hattori, and S Nakamura, and T Yamamoto, and T Yoshida, and T Katagiri
October 1993, Leukemia research,
Copied contents to your clipboard!